IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 202 filers reported holding IMPAX LABORATORIES INC in Q4 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $98,362,000 | 8.33% |
| Krensavage Asset Management, LLC | 587,882 | $18,824,000 | 6.75% |
| Hound Partners | 6,757,558 | $216,377,000 | 5.88% |
| Asymmetry Capital Management, L.P. | 62,050 | $1,987,000 | 5.18% |
| Orbimed Advisors | 6,776,100 | $216,971,000 | 2.28% |
| Pennant Capital Management, LLC | 2,083,074 | $66,700,000 | 1.90% |
| UNIVERSITY OF NOTRE DAME DU LAC | 41,104 | $1,316,000 | 1.62% |
| Tygh Capital Management, Inc. | 137,975 | $4,418,000 | 1.29% |
| JW Asset Management, LLC | 53,373 | $1,709,000 | 1.12% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,784 | $8,863,000 | 0.93% |